Humana a major US health insurer and Mark Cuban Cost Plus Drugs are in early discussions to launch a pharmacy partnership that aims to simplify drug access and reduce prescription-medication costs for employers and insured members.
Glimpse:
The proposed collaboration would use a “direct-to-employer / direct-to-consumer” distribution model, bypassing traditional pharmacy-benefit-managers (PBMs), streamlining the supply chain, and potentially offering medications to patients at net prices closer to manufacturer cost. Humana’s specialty-pharmacy arm CenterWell may play a key role in dispensing, improving access especially for its large membership base (millions of Medicare Advantage and employer-covered members).
At the recent Forbes Healthcare Summit, Humana CEO Jim Rechtin and Cuban publicly confirmed they are working on ways to “improve the patient experience at the pharmacy.” The idea is to leverage Cost Plus Drugs’ transparent pricing model which sets drug prices at manufacturer cost plus a fixed markup along with Humana’s insurance & pharmacy infrastructure, to deliver medications more affordably.
Under the proposed model, employers (rather than traditional PBMs) may contract directly to provide prescription drugs potentially translating into lower out-of-pocket costs for patients and lower overall spend for payers. For patients, this could mean fewer intermediaries, simpler billing, more transparent pricing and improved access, especially for generics and high-cost chronic medications.
While the plans are still in early stages and no detailed agreement has been publicly released, both sides emphasised that the partnership could disrupt current drug-supply economics reducing costs and streamlining distribution from manufacturer to consumer.
“We’re trying to take a drug from the plant to the consumer as efficiently as possible removing layers of markup and complexity so patients can get their meds at real price.”
By
HB Team
Related News
